Spoken Alpha
Kenvue Inc.
Kenvue manufactures and markets over-the-counter medicines, skin care, and personal care products across three segments: Self Care (including pain relief and cold/allergy treatments), Skin Health and Beauty (dermatological solutions), and Essential Health (oral care, baby care, and wound care).
Kenvue Inc is a Consumer Defensive company operating in Household & Personal Products with a $34.14B market cap.
Most recent reported earnings: Q3 FY2026 (Nov 1, 2026).
9 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-08-30.
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
Peers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for KVUE.
$ curl https://api.spokenalpha.com/v1/companies/KVUEFAQ
Spoken Alpha indexes KVUE's earnings call transcripts at https://spokenalpha.com/companies/KVUE. Each call links to attributed speakers and parsed analyst Q&A. Kenvue Inc.'s own investor relations page is at https://investors.kenvue.com/overview/default.aspx.
Kenvue Inc. (KVUE) held its most recent earnings call on 2025-08-07, covering fiscal Q2 2025.
Kenvue Inc. (KVUE) operates in the Consumer Defensive sector (Household & Personal Products industry).
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-11-01 | — | $0.28 | — | — | — | — | EODHD |
| Q2 FY2026 | 2026-08-05 | $0.31 | $0.32 | -3.1% | $3.96B | — | — | EODHD |
| Q1 FY2026 | 2026-05-06 | $0.32 | $0.26 | +23.1% | $3.91B | — | — | EODHD |
| Q4 FY2025 | 2026-02-16 | $0.27 | $0.22 | +22.7% | $3.78B | — | — | EODHD |
| Q3 FY2025 | 2025-11-02 | $0.28 | $0.26 | +7.7% | $3.76B | — | — | EODHD |
| Q2 FY2025 | 2025-08-06 | $0.29 | $0.28 | +3.6% | $3.84B | — | — | EODHD |
| Q1 FY2025 | 2025-05-07 | $0.24 | $0.23 | +4.3% | $3.74B | — | — | EODHD |
| Q4 FY2024 | 2025-02-05 | $0.26 | $0.26 | 0.0% | $3.66B | — | — | EODHD |
| Q3 FY2024 | 2024-11-06 | $0.28 | $0.27 | +3.7% | $3.90B | — | — | EODHD |
| Q2 FY2024 | 2024-08-05 | $0.32 | $0.28 | +14.3% | $4.00B | — | — | EODHD |
| Q1 FY2024 | 2024-05-06 | $0.28 | $0.25 | +12.0% | $3.89B | — | — | EODHD |
| Q4 FY2023 | 2024-02-07 | $0.31 | $0.28 | +10.7% | $3.67B | — | — | EODHD |
| Q3 FY2023 | 2023-10-25 | $0.31 | $0.31 | 0.0% | $3.92B | — | — | EODHD |
| Q2 FY2023 | 2023-07-19 | $0.32 | $0.30 | +6.7% | $4.01B | — | — | EODHD |
| Q1 FY2023 | 2023-06-01 | $0.19 | $0.32 | -40.6% | $3.85B | — | — | EODHD |
| Q4 FY2022 | 2023-01-03 | $0.91 | $0.00 | — | $3.76B | — | — | EODHD |
| Q2 FY2022 | 2022-08-29 | $0.22 | $0.00 | — | $3.80B | — | — | EODHD |
Source: EODHD. KVUE reported actuals as published; sparse fields render as —.